AR
IMMU

Advisory Research’s Immunomedics Inc IMMU Stock Holding History

Advisory Research’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,229
Closed -$360K – 369
2020
Q3 		$360K Sell
4,229
-8,265
-66% -$418K 0.04% 256
2020
Q2 		$443K Buy
+12,494
New +$365K 0.04% 251

Advisory Research's IMMU Position: Q4 2020 in Review

Advisory Research sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,229 shares — an estimated $360K sold.

Advisory Research first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $443K in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Advisory Research reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Advisory Research sold 4,229 Immunomedics Inc shares in Q4 2020, an estimated $360K.
  • Advisory Research first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Advisory Research's Immunomedics Inc position peaked at $443K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.